Venture Visionary Partners’s iShares Biotechnology ETF IBB Stock Holding History

Venture Visionary Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+1,073	New	+$184K	0.01%	663
2022 Q3	–	Sell	-1,170	Closed	-$138K	–	956
2022 Q2	$138K	Sell	1,170 -480	-29%	-$57K	0.01%	535
2022 Q1	$214K	Sell	1,650 -260	-14%	-$33.9K	0.01%	465
2021 Q4	$291K	Sell	1,910 -30	-2%	-$4.64K	0.02%	419
2021 Q3	$313K	Hold	1,940	–	–	0.02%	396
2021 Q2	$317K	Buy	1,940 +140	+8%	+$21.6K	0.03%	377
2021 Q1	$271K	Hold	1,800	–	–	0.02%	383
2020 Q4	$272K	Buy	+1,800	New	+$257K	0.03%	327

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Venture Visionary Partners's IBB Position: Q2 2026 in Review

Venture Visionary Partners opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,073 shares worth $204K. The stake represents 0.01% of the portfolio and ranks #663 among its holdings. This is a return to the name: Venture Visionary Partners previously reported a position in IBB as recently as Q2 2022.

Venture Visionary Partners first reported a position in IBB in Q4 2020 and has held it in 8 quarters since. The position peaked at $317K in Q2 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Venture Visionary Partners held 1,073 shares of iShares Biotechnology ETF worth $204K as of Q2 2026.
iShares Biotechnology ETF was a new Venture Visionary Partners position in Q2 2026.
iShares Biotechnology ETF made up 0.01% of Venture Visionary Partners's portfolio in Q2 2026, its #663 holding.
Venture Visionary Partners first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 8 quarters since.
Venture Visionary Partners's iShares Biotechnology ETF position peaked at $317K in Q2 2021.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.